Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jan;194(1):60-66.
doi: 10.1007/s00066-017-1207-9. Epub 2017 Sep 8.

Lethal outcome after pelvic salvage radiotherapy in a patient with prostate cancer due to increased radiosensitivity : Case report and literature review

Affiliations
Review

Lethal outcome after pelvic salvage radiotherapy in a patient with prostate cancer due to increased radiosensitivity : Case report and literature review

Antje Fahrig et al. Strahlenther Onkol. 2018 Jan.

Abstract

Background: In general, late side effects after salvage radiotherapy (RT) for prostate cancer are below 10%. Patients with impaired DNA repair ability and genetic instability can have significantly increased reactions after RT.

Case, clinical follow-up, and examination: We present a patient who experienced severe side effects after additive RT for prostate cancer and died from the complications 25 months after RT. Imaging (MR) is shown as well as three-color fluorescence in situ hybridization. The blood sample testing revealed that radiosensitivity was increased by 35-55%. We undertook a review of the literature to give an overview over the tests established that are currently considered useful.

Conclusion: This case highlights that the identification of patients with increased radiosensitivity is an important task in radiation protection. Groups of patients who should be screened have to be found and corresponding research facilities have to be set up.

Keywords: DNA repair; Fluorescence in situ hybridization; Radiation protection; Radiation toxicity; Radiosensitivity.

PubMed Disclaimer

References

    1. Radiol Oncol. 2014 Jan 22;48(1):80-6 - PubMed
    1. Cancer Discov. 2014 Feb;4(2):155-65 - PubMed
    1. Curr Opin Immunol. 1999 Aug;11(4):443-7 - PubMed
    1. Genet Anal. 1998 Oct;14(4):121-4 - PubMed
    1. Neurology. 1984 Oct;34(10):1331-5 - PubMed

MeSH terms

LinkOut - more resources